The developing world could use AstraZeneca's coronavirus vaccine, says Johns Hopkins doctor

The Oxford-AstraZeneca coronavirus vaccine is cheaper and has less onerous storage conditions versus other candidates from Pfizer-BioNTech and Moderna, says Amesh Adalja of the Johns Hopkins Center for Health Security.
Mon, Nov 23 202011:14 PM EST